TUMORI J, vol.96, no.3, pp.400-404, 2010 (Journal Indexed in SCI)
Aims. To evaluate activity and toxicity of cisplatin plus docetaxel combination in the first-line treatment of chemotherapy-naive patients with metastatic non-small cell lung cancer.